Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 154,270 | 196,808 | 139,800 | 142,071 | 89,286 |
| Marketable Securities | 52,055 | 38,156 | 66,812 | 94,581 | 135,894 |
| Receivables | 24,992 | 22,497 | 18,752 | 17,887 | 17,843 |
| Inventories | 3,874 | 4,106 | 3,943 | 3,905 | 3,114 |
| Other current assets | 29,135 | 0 | 0 | 0 | 0 |
| TOTAL | $276,533 | $275,606 | $241,579 | $273,502 | $255,511 |
| Non-Current Assets | |||||
| PPE Net | 1,544 | 1,642 | 1,574 | 1,755 | 1,984 |
| Investments And Advances | 0 | 0 | 2,005 | 2,006 | 7,676 |
| Other Non-Current Assets | 15,956 | 28,057 | 8,936 | 9,304 | 9,738 |
| TOTAL | $17,500 | $29,699 | $12,515 | $13,065 | $19,398 |
| Total Assets | $294,033 | $305,305 | $254,094 | $286,567 | $274,909 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,440 | 1,603 | 881 | 2,309 | 3,040 |
| Accrued Expenses | 58,371 | 69,121 | 64,698 | 53,211 | 55,611 |
| Other current liabilities | 2,063 | 678 | 1,124 | 524 | 1,360 |
| TOTAL | $66,337 | $73,718 | $68,866 | $58,123 | $62,008 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 310,775 | 311,260 | 311,205 | 311,576 | 252,541 |
| TOTAL | $310,775 | $311,260 | $311,205 | $311,576 | $252,541 |
| Total Liabilities | $377,112 | $384,978 | $380,071 | $369,699 | $314,549 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,297 | 5,280 | 5,039 | 5,036 | 5,009 |
| Common Shares | 8 | 8 | 8 | 8 | 8 |
| Retained earnings | -1,220,047 | -1,178,648 | -1,217,368 | -1,165,556 | -1,111,974 |
| Other shareholders' equity | 87 | 191 | 372 | 196 | 301 |
| TOTAL | $-83,079 | $-79,673 | $-125,977 | $-83,132 | $-39,640 |
| Total Liabilities And Equity | $294,033 | $305,305 | $254,094 | $286,567 | $274,909 |